Suppr超能文献

用于活体成像细胞外蛋白酶表达的双重功能、受体靶向荧光探针。

Dual-functional, receptor-targeted fluorogenic probe for in vivo imaging of extracellular protease expressions.

机构信息

National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Maryland 20892, United States.

出版信息

Bioconjug Chem. 2011 Jun 15;22(6):1001-5. doi: 10.1021/bc200005w. Epub 2011 May 24.

Abstract

Herein, we report a new type of in vivo fluorogenic probe that enables simultaneous and active targeting of overexpressed receptors, α(V)β(3) integrins, and extracellular proteases, matrix metalloproteinases (MMPs), in the tumor regions. This c(RGDyK)-conjugated MMP fluorogenic probe efficiently targets the tumor regions with high retention time while maintaining receptor binding affinity and substrate activity. The probe minimizes nonspecific accumulation, thus demonstrating improved tumor-to-background signal ratio (T/N) in both α(V)β(3) integrin- and MMP-overexpressing U87MG tumor-bearing mouse model. This strategy can be easily tuned for a wide array of applications targeting various receptors and extracellular proteases in vivo.

摘要

在此,我们报告了一种新型的活体荧光探针,它能够同时主动靶向过表达的受体、α(V)β(3)整合素和细胞外蛋白酶、基质金属蛋白酶(MMPs)在肿瘤区域。这种 c(RGDyK)-缀合的 MMP 荧光探针能够高效地靶向肿瘤区域,同时保持受体结合亲和力和底物活性。该探针最大限度地减少了非特异性积累,因此在 α(V)β(3)整合素和 MMP 过表达的 U87MG 荷瘤小鼠模型中,提高了肿瘤与背景信号的比值(T/N)。这种策略可以很容易地针对各种受体和细胞外蛋白酶在体内的广泛应用进行调整。

相似文献

1
Dual-functional, receptor-targeted fluorogenic probe for in vivo imaging of extracellular protease expressions.
Bioconjug Chem. 2011 Jun 15;22(6):1001-5. doi: 10.1021/bc200005w. Epub 2011 May 24.
2
Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.
Bioconjug Chem. 2009 Aug 19;20(8):1611-7. doi: 10.1021/bc900155j. Epub 2009 Jul 22.
4
FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues.
Bioconjug Chem. 2014 Nov 19;25(11):1925-41. doi: 10.1021/bc500452y. Epub 2014 Oct 22.
5
Near-Infrared Confocal Laser Endomicroscopy Detects Colorectal Cancer via an Integrin αvβ 3 Optical Probe.
Mol Imaging Biol. 2015 Aug;17(4):450-60. doi: 10.1007/s11307-015-0825-9.
6
Specific detection of integrin αvβ3 by light-up bioprobe with aggregation-induced emission characteristics.
J Am Chem Soc. 2012 Jun 13;134(23):9569-72. doi: 10.1021/ja302369e. Epub 2012 Jun 1.
7
In vivo angiogenesis imaging of solid tumors by alpha(v)beta(3)-targeted, dual-modality micellar nanoprobes.
Exp Biol Med (Maywood). 2010 Aug;235(8):957-65. doi: 10.1258/ebm.2010.010096.
8
Ligands for mapping alphavbeta3-integrin expression in vivo.
Acc Chem Res. 2009 Jul 21;42(7):969-80. doi: 10.1021/ar800243b.
9
Integrin and matrix metalloprotease dual-targeting with an MMP substrate-RGD conjugate.
Org Biomol Chem. 2013 Jan 21;11(3):448-52. doi: 10.1039/c2ob26926k. Epub 2012 Nov 29.
10
Dual targeting of integrin αvβ3 and matrix metalloproteinase-2 for optical imaging of tumors and chemotherapeutic delivery.
Mol Cancer Ther. 2014 Jun;13(6):1514-25. doi: 10.1158/1535-7163.MCT-13-1067. Epub 2014 Apr 15.

引用本文的文献

1
Dual targeting of integrin αvβ3 and matrix metalloproteinase-2 for optical imaging of tumors and chemotherapeutic delivery.
Mol Cancer Ther. 2014 Jun;13(6):1514-25. doi: 10.1158/1535-7163.MCT-13-1067. Epub 2014 Apr 15.
4
Fluorescence-guided surgery with live molecular navigation--a new cutting edge.
Nat Rev Cancer. 2013 Sep;13(9):653-62. doi: 10.1038/nrc3566. Epub 2013 Aug 8.
5
Molecular beacons of xeno-nucleic acid for detecting nucleic acid.
Theranostics. 2013 May 5;3(6):395-408. doi: 10.7150/thno.5935. Print 2013.
6
Optical imaging of tumor microenvironment.
Am J Nucl Med Mol Imaging. 2013;3(1):1-15. Epub 2013 Jan 5.
7
In vivo optical imaging of membrane-type matrix metalloproteinase (MT-MMP) activity.
Mol Pharm. 2011 Dec 5;8(6):2331-8. doi: 10.1021/mp2002297. Epub 2011 Nov 1.

本文引用的文献

1
Why integrin as a primary target for imaging and therapy.
Theranostics. 2011;1:30-47. doi: 10.7150/thno/v01p0030.
2
Integrin Targeted Imaging and Therapy.
Theranostics. 2011 Jan 12;2011(1):28-29. doi: 10.7150/thno/v01p0028.
3
Real-time video imaging of protease expression in vivo.
Theranostics. 2011;1:18-27. doi: 10.7150/thno/v01p0018. Epub 2011 Jan 12.
4
Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications.
Acc Chem Res. 2011 Feb 15;44(2):83-90. doi: 10.1021/ar1000633. Epub 2010 Nov 9.
5
Emerging principles in protease-based drug discovery.
Nat Rev Drug Discov. 2010 Sep;9(9):690-701. doi: 10.1038/nrd3053.
6
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.
Adv Drug Deliv Rev. 2011 Mar 18;63(3):136-51. doi: 10.1016/j.addr.2010.04.009. Epub 2010 May 2.
7
Activatable molecular probes for cancer imaging.
Curr Top Med Chem. 2010;10(11):1135-44. doi: 10.2174/156802610791384270.
8
Matrix metalloproteinases: regulators of the tumor microenvironment.
Cell. 2010 Apr 2;141(1):52-67. doi: 10.1016/j.cell.2010.03.015.
9
Peptides and peptide hormones for molecular imaging and disease diagnosis.
Chem Rev. 2010 May 12;110(5):3087-111. doi: 10.1021/cr900361p.
10
Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival.
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4317-22. doi: 10.1073/pnas.0910261107. Epub 2010 Feb 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验